Investigation into pharmaceutical manufacturing establishments is also initiated to confirm overall manufacturing and quality control.
The authorities have taken measures to stop manufacturing and selling six drugs, including Binex’s diabetes and depression treatment, which are known to have manipulated the dosage of pharmaceutical ingredients.
The Ministry of Food and Drug Safety (Director Kang-rip Kim) announced that it will decide on temporary manufacturing, sales suspension, and collection measures for six drugs of the drug manufacturer’Vinex’ and initiate an investigation into the relevant manufacturing plant (located in Busan).
The six medicines taken this time are amorin tablet (glimepiride), selectin capsule (fluoxetine hydrochloride), daxfen tablet (dexibuprofen), ropesin tablet 250mg (ciprofloxacin hydrochloride hydrate), selectin capsule 10mg (fluoxetine hydrochloride), cardil tablet It is 1 milligram (doxazosin mesylate).
This measure was determined by the Ministry of Food and Drug Safety as a precautionary measure for submitting a recovery plan for the item manufactured differently from the matters for which’Binex’ was licensed or reported to the Busan Regional Food and Drug Administration. We conducted an investigation to confirm.
The Ministry of Food and Drug Safety has distributed a safety bulletin to doctors, pharmacists, and consumers, asking experts such as medical and pharmacists to convert the product to other alternative medicines and cooperate so that product collection can be performed properly.
In addition, through the Ministry of Health and Welfare and the Health Insurance Review and Assessment Service, it requested hospitals and clinics to restrict prescriptions for the product.
An official from the Ministry of Food and Drug Safety said, “We plan to promptly carry out on-site investigations and necessary measures for Binex.”
Copyright owner © Doctor Shinmun Unauthorized reproduction and redistribution prohibited